logo
logo
Sign in

Alertgy: Solving Significant Global Problems for Diabetics

avatar
Insights Success
Alertgy: Solving Significant Global Problems for Diabetics
Today, diseases such as diabetes are spreading at a very fast rate mainly due to more relaxed lifestyles, genes, and choices of food.
 
The World Health Organization (WHO) and Centers for Disease Control (CDC) currently report that there are over 420 million diabetics world-wide today and that number is growing at an alarming rate.
 
Diabetics presently don’t have a “noninvasive” wearable method of continuously measuring their blood glucose levels and resultant trends. The number of borderline diabetics (pre-diabetics) is also increasing. In the US alone one-third of the population is a borderline diabetic: a noninvasive wearable device which would affect their behavior to prevent them from becoming diabetic through personal and continuous feedback is sorely needed.
 
Addressing this demand, Alertgy provides an inexpensive means to fill these major unmet needs in a mature market. The Alertgy Non-Invasive Continuous Glucose Monitor (NICGM) system is the solution. It consists of a wristband containing a biosensor device that is enabled by a smartphone application which provides diabetics with on-demand real-time levels and trends.
 
When Blood glucose levels become too high or too low, the ALERTGY device, via the patient’s cell phone, ALERTS (hence the word ALERT GY) the patient to take some sort of remedial action. If the alert is not heeded, their spouse, family member, doctor, etc. will be alerted to the situation and action taken.
 
Unchallenged Global Leader in a Non-invasive Wearable
 
Alertgy is the first company to develop a truly non-invasive wearable device. which continuously monitors blood glucose and alerts when needed. In terms of its wearability, non-invasiveness, and low cost, Alertgy currently has no direct competition in this market.
 
Over 95% of the existing blood glucose monitoring devices consist of the current self-monitoring blood glucometers (SMBGs) which use a lancet for diabetics to prick themselves, then place their blood on a  test strip that is inserted into a glucometer system which provides a blood glucose reading. The other 5% of the current continuous blood glucose monitoring monitors (CGMs) are those sold by companies such as Dexcom and Abbott.
 
Architect behind Alertgy
 
Marc Rippen, the founder and CEO of Alertgy is a former Army Officer who founded and worked with several successful high technology startups in the past, taking one from seed to public in less than 2 years. Alertgy was founded as a result of Marc saving his wife from slipping into a diabetic coma one Sunday morning. This created a resolve to develop a system that would alert him when her blood glucose levels are too high or low and to help her manage her diabetes better.
 
Marc leads by example, he never asks anyone to do what he himself would not do. He also works to provide his employees the ability to grow themselves on the job by mentoring them in new tasks that allow them to develop skills and knowledge as they wish to.
collect
0
avatar
Insights Success
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more